• 880 Citations
  • 19 h-Index
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Potito Rosario Scalzulli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 22 Similar Profiles
Erythroid Precursor Cells Medicine & Life Sciences
Erythropoietin Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Chronic Kidney Failure Medicine & Life Sciences
Thrombocytosis Medicine & Life Sciences
Erythropoiesis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2019

  • 880 Citations
  • 19 h-Index
  • 58 Article

Leukemia-associated immunophenotypes subdivided in “categories of specificity” improve the sensitivity of minimal residual disease in predicting relapse in acute myeloid leukemia

Rossi, G., Giambra, V., Minervini, M. M., De Waure, C., Mancinelli, S., Ciavarella, M., Sinisi, N. P., Scalzulli, P. R., Carella, A. M. & Cascavilla, N., Jan 1 2019, (Accepted/In press) In : Cytometry Part B - Clinical Cytometry.

Research output: Contribution to journalArticle

Residual Neoplasm
Acute Myeloid Leukemia
Sensitivity and Specificity
3 Citations (Scopus)

Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP)

Pavone, V., Mele, A., Carlino, D., Specchia, G., Gaudio, F., Perrone, T., Mazza, P., Palazzo, G., Guarini, A., Loseto, G., Eleonora, P., Cascavilla, N., Scalzulli, P., Melpignano, A., Quintana, G., Di Renzo, N., Tarantini, G. & Capalbo, S., Oct 1 2018, In : Annals of Hematology. 97, 10, p. 1817-1824 8 p.

Research output: Contribution to journalArticle

Salvage Therapy
Life Change Events
Hodgkin Disease

Cost-effectiveness of on-demand plerixafor added to chemotherapy and granulocyte-colony stimulating factor for peripheral blood stem cell mobilization in multiple myeloma

Milone, G., Martino, M., Leotta, S., Spadaro, A., Zammit, V., Cupri, A., Avola, G., Camuglia, M. G., Di Marco, A., Scalzulli, P., Morelli, M., Olivieri, A. & Tripepi, G., Jan 2018, In : Leukemia and Lymphoma. 59, 1, p. 42-48 7 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Granulocyte Colony-Stimulating Factor
Multiple Myeloma
Cost-Benefit Analysis
Drug Therapy
2 Citations (Scopus)
Residual Neoplasm
Plasma Cells
Multiple Myeloma
Stem Cells
1 Citation (Scopus)

Validation of PLASMIC score and follow-up data in a cohort of patients with suspected microangiopathies from Southern Italy

Tiscia, G. L., Ostuni, A., Cascavilla, N., Cappucci, F., Scalzulli, P., Battista, C., Abrescia, A., Aucella, F., Buquicchio, C., Brigante, M., D’Andrea, G., Di Paolo, B., Giordano, G., Infante, B., Piano, S., Ranieri, P., Tullo, L. & Grandone, E., Aug 1 2018, In : Journal of Thrombosis and Thrombolysis. 46, 2, p. 174-179 6 p.

Research output: Contribution to journalArticle

Area Under Curve
Thrombotic Microangiopathies
Thrombotic Thrombocytopenic Purpura